George Farmer
Stock Analyst at Scotiabank
(1.02)
# 3,448
Out of 4,810 analysts
71
Total ratings
25.64%
Success rate
-11.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TPST Tempest Therapeutics | Downgrades: Sector Perform | $91 → $9 | $7.46 | +20.64% | 4 | Apr 10, 2025 | |
| ADAP Adaptimmune Therapeutics | Maintains: Sector Outperform | $3.15 → $1.4 | $0.25 | +461.12% | 2 | Mar 21, 2025 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $29.06 | +41.09% | 4 | Feb 28, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $47 → $52 | $16.06 | +223.79% | 4 | Feb 27, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $59.91 | +33.53% | 8 | Feb 20, 2025 | |
| BIIB Biogen | Maintains: Sector Outperform | $244 → $224 | $116.98 | +91.49% | 3 | Feb 13, 2025 | |
| VKTX Viking Therapeutics | Initiates: Sector Outperform | $102 | $23.11 | +341.37% | 1 | Feb 13, 2025 | |
| SAGE Sage Therapeutics | Maintains: Sector Outperform | $14 → $12 | $7.54 | +59.15% | 5 | Feb 12, 2025 | |
| INMB INmune Bio | Maintains: Sector Outperform | $22 → $23 | $7.47 | +207.90% | 2 | Feb 11, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $18 → $16 | $11.33 | +41.22% | 3 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $6.03 | +65.84% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Outperform | $439 → $715 | $605.38 | +18.11% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $5.57 | +312.93% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $1.71 | +1,069.59% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $21 → $41 | $1.73 | +2,269.94% | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $33.74 | +125.25% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $3.12 | +316.67% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $66 | $61.43 | +7.44% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $26.24 | +315.40% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $58.46 | +48.82% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $1.19 | +2,673.11% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $0.99 | +3,948.58% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $36.54 | -26.11% | 3 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $75 | $81.45 | -7.92% | 3 | Apr 29, 2020 |
Tempest Therapeutics
Apr 10, 2025
Downgrades: Sector Perform
Price Target: $91 → $9
Current: $7.46
Upside: +20.64%
Adaptimmune Therapeutics
Mar 21, 2025
Maintains: Sector Outperform
Price Target: $3.15 → $1.4
Current: $0.25
Upside: +461.12%
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $29.06
Upside: +41.09%
NewAmsterdam Pharma Company
Feb 27, 2025
Maintains: Sector Outperform
Price Target: $47 → $52
Current: $16.06
Upside: +223.79%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $59.91
Upside: +33.53%
Biogen
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $116.98
Upside: +91.49%
Viking Therapeutics
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $23.11
Upside: +341.37%
Sage Therapeutics
Feb 12, 2025
Maintains: Sector Outperform
Price Target: $14 → $12
Current: $7.54
Upside: +59.15%
INmune Bio
Feb 11, 2025
Maintains: Sector Outperform
Price Target: $22 → $23
Current: $7.47
Upside: +207.90%
Syndax Pharmaceuticals
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $16
Current: $11.33
Upside: +41.22%
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $6.03
Upside: +65.84%
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $605.38
Upside: +18.11%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $5.57
Upside: +312.93%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $1.71
Upside: +1,069.59%
Sep 27, 2024
Maintains: Sector Outperform
Price Target: $21 → $41
Current: $1.73
Upside: +2,269.94%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $33.74
Upside: +125.25%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $3.12
Upside: +316.67%
Dec 19, 2023
Initiates: Sector Outperform
Price Target: $66
Current: $61.43
Upside: +7.44%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $26.24
Upside: +315.40%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $58.46
Upside: +48.82%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $1.19
Upside: +2,673.11%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $0.99
Upside: +3,948.58%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $36.54
Upside: -26.11%
Apr 29, 2020
Maintains: Outperform
Price Target: $89 → $75
Current: $81.45
Upside: -7.92%